Clinical Trial Update: Safety and Efficacy of PG101 for Dry Eye Syndrome [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of Phase 1 and Phase 2 trials evaluating the safety and efficacy of PG101 for dry eye syndrome conducted by Rhodes Pharmaceut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• PG101

Snippet

Sponsor: Rhodes Pharmaceuticals, L.P. | Conditions: Dry Eye Syndrome | Phase 1, Phase 2 | Status: COMPLETED